Clinical value of serum AFP and PIVKA‐II for diagnosis, treatment and prognosis of hepatocellular carcinoma - Tian - 2023 - Journal of Clinical Laboratory Analysis - Wiley Online Library
PIVKA-II serves as a potential biomarker that complements AFP for the diagnosis of hepatocellular carcinoma | BMC Cancer | Full Text
Clinical utility of PIVKA-II in the diagnosis of hepatocellular carcinoma | Synnovis
Value of AFP and PIVKA-II in diagnosis of HBV-related hepatocellular carcinoma and prediction of vascular invasion and tumor dif
Clinical value of serum AFP and PIVKA‐II for diagnosis, treatment and prognosis of hepatocellular carcinoma - Tian - 2023 - Journal of Clinical Laboratory Analysis - Wiley Online Library
PIVKA-II, a biomarker of liver cells for the management of hepatocellular carcinoma (HCC) | Fujirebio
PIVKA-II: A biomarker for diagnosing and monitoring patients with pancreatic adenocarcinoma | PLOS ONE
Diagnostic value of the γ-glutamyltransferase and alanine transaminase ratio, alpha-fetoprotein, and protein induced by vitamin K absence or antagonist II in hepatitis B virus-related hepatocellular carcinoma | Scientific Reports
View of PIVKA-II or AFP has better diagnostic properties for hepatocellular carcinoma diagnosis in high-risk patients | Journal of Circulating Biomarkers
The diagnostic performance of PIVKA-II in metabolic and viral hepatocellular carcinoma: a pilot study
Clinical evaluation of Elecsys PIVKA-II for patients with advanced hepatocellular carcinoma | PLOS ONE
Premium Photo | Pivka ii or protein induced by vitamin k ii test a screening marker for hepatocellular carcinoma
Real impact of tumor marker AFP and PIVKA-II in detecting very small hepatocellular carcinoma (≤ 2 cm, Barcelona stage 0) - assessment with large number of cases
Role of PIVKA-II in screening for malignancies at a hepatobiliary and pancreatic disease center: A large-scale real-world study - ScienceDirect
Pivka-II Monoclonal Antibody (DCP tumor marker) - China Pivka-II, Antibody | Made-in-China.com
Clinical course of the patient. a Tumor markers (AFP, PIVKA-II)... | Download Scientific Diagram
Medicina | Free Full-Text | Utility of PIVKA-II and AFP in Differentiating Hepatocellular Carcinoma from Non-Malignant High-Risk Patients
Frontiers | Changes and Clinical Significance of PIVKA-II in Hepatitis E Patients
Efficacy of PIVKA-II in prediction and early detection of hepatocellular carcinoma: a nested case-control study in Chinese patients | Scientific Reports
Assessment of Pivka II as Tumour Marker in Hepatocellular Carcinoma
Epitope characterization of an anti-PIVKA-II antibody and evaluation of a fully automated chemiluminescent immunoassay for PIVKA-II - ScienceDirect
Effectiveness of PIVKA-II in the detection of hepatocellular carcinoma based on real-world clinical data | BMC Cancer | Full Text
Clinical utility of PIVKA-II in the diagnosis of hepatocellular carcinoma - Clinical Laboratory int.
Real impact of tumor marker AFP and PIVKA-II in detecting very small hepatocellular carcinoma (≤ 2 cm, Barcelona stage 0) - assessment with large number of cases
Elecsys® PIVKA-II
